Diabetes Management Market: Worldwide Study on Top Players | Medtronic plc, F.Hoffmann-La-Roche Ltd., Abbott Laboratories Inc., Johnson & Johnson, Novo Nordisk A/S, Bayer AG

Global Diabetes Management Market Analysis and Forecast 2019-2028
Market Introduction:

The global diabetes management market is expected to witness a strong growth rate of 8.4% during the forecast period of 2022-2028. The growth of the global diabetes management market is attributed to the rising incidence of diabetes among the younger as well as the geriatric population. Moreover, disease like obesity and the prevalence of junk food and alcohol among the younger population is expected to escalate the number of diabetic patients across the globe, which in turn will fuel the growth of the diabetes management market.

Download PDF Sample of Diabetes Management Devices Market report @ https://www.themarketinsights.com/request-sample/265147

In addition, the continuous R&D in the healthcare sector along with the introduction of innovative devices gives a thrust to the global diabetes management devices. Moreover, the higher incidences of diabetes (Type I & Type II) in the geriatric population across the globe are high which is increasing the demand for devices such as insulin pens and pumps and hence drives the growth of the diabetes management devices market.
Market Segmentation:

The global diabetes management market is segmented on the basis of device type, end-user, distribution channel, and region. Based on device type, the market is divided into blood glucose monitoring devices and insulin delivery devices. Further, blood glucose monitoring device is divided into, self-monitoring devices and continuous glucose monitoring devices, and continuous glucose monitoring device are segmented into insulin pens, insulin pumps, insulin syringes, and others including jet injectors. On the basis of end-user, the market is segmented into diagnostics centers, hospitals, and home care.

Get Discount @ https://www.themarketinsights.com/check-discount/265147

Based on the distribution channel, the market is segmented into retail pharmacies, hospital pharmacies, diabetes centres/clinics, and E-commerce websites. Based on region, the market is divided into North America, Latin America, Western Europe, Eastern Europe, Asia Pacific, and Middle East & Africa. Further, North America is divided into US and Canada. Latin America is further segmented on the basis of Brazil, Mexico, and the Rest of Latin America. Western Europe is further segmented into Germany, the UK, France, Spain, Italy, Benelux, Nordic, and the rest of western Europe.

Eastern Europe is segmented into Russia, Poland, and the rest of Eastern Europe. Based on the Asia Pacific, the market is further segmented into China, India, Japan, South Korea, Australia, ASEAN (Indonesia, Vietnam, Malaysia, etc.) countries, and the rest of Asia Pacific. Lastly, on the basis of the Middle East & Africa market is segmented into GCC Countries, South Africa, Turkey, and the rest of the Middle East & Africa.

Market structure and competitive landscape:

The global diabetes management market is fragmented in nature, some of the prominent players that contribute significantly to the global enterprise resource planning market include, Medtronic plc, F.Hoffmann-La-Roche Ltd., Abbott Laboratories Inc., Johnson & Johnson, Novo Nordisk A/S, Bayer AG, Insulet Corp., Sanofi SA, Lifescan Inc., B Braun Melsungen AG, Rossmax International Ltd., Eli Lilly and Company, and Ypsomed Holdings are some of the key players operating in the market.

Product Launches, Mergers & Acquisitions, joint ventures, and R&D activities are key strategies adopted by the players in the global diabetes management market. These companies adopt numerous approaches to strengthen their market share and gain a competitive edge over other competitors in the market.

Report Customization available as per requirements @ https://www.themarketinsights.com/request-customization/265147

Some of the key developments in the North America Cooking Robots market include:

1. In May 2021, Eli Lily and Company collaborated with DexCom, Inc., Glooko Inc., myDiabby Healthcare, and Roche with a goal to integrate data and technology to help streamline diabetes management.

2. In November 2020, a Denmark-based bio-medical device manufacturer Novo Nordisk A/S acquired the 100% share of Emisphere Technologies.

3. In April 2020, a Switzerland-based company Ypsomed partnered with the US-based company DexCom, Inc. for the integration of DexCom's G6 sensors with its mylife YpsoPump data to produce a hybrid system.

Partial Table of Content:

Chapter One: Market Introduction
1.1. Scope of Study
1.2. Problem Statement
1.3. Market Segmentation

Chapter Two: Assumptions and Acronyms

Chapter Three: Executive Summary
3.1. Global Market in2022
3.2. Analyst Insights & Recommendations
3.3. Growth Opportunities and Key Strategies
3.4. Supply-side and Demand-side Trends
Chapter Four: Research Methodology

Contact us:

Jessica Joyal
+16146022897
Email: sales@themarketinsights.com
Visit our website: www.themarketinsights.com

About:

Delivering foresights along with statistical analysis of the operational business industry impacts has been our foremost priority. With the constant developments in the research & development industry, we have always challenged the conventional research methodologies and discovered new research tactics to evolve the growing B2B requirements.

This release was published on openPR.